The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab plus low-dose apatinib and SOX in the first-line treatment of advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: A single-arm, dose escalation and expansion study (SPACE study).
 
Xiaofeng Chen
No Relationships to Disclose
 
Hao Xu
No Relationships to Disclose
 
Deqiang Wang
No Relationships to Disclose
 
Xiaobing Chen
No Relationships to Disclose
 
Kangxin Wang
No Relationships to Disclose
 
Guangfu Jin
No Relationships to Disclose
 
Yongbin Ding
No Relationships to Disclose
 
Jie Tang
No Relationships to Disclose
 
Yueyu Fang
No Relationships to Disclose
 
Hui Sun
No Relationships to Disclose
 
Qiusheng Jiang
No Relationships to Disclose
 
Lanlan Pan
No Relationships to Disclose
 
Yitong Tian
No Relationships to Disclose
 
Rong Wang
No Relationships to Disclose
 
Tongpeng Xu
No Relationships to Disclose
 
Lijuan Meng
No Relationships to Disclose
 
Fengyuan Li
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Fen Guo
No Relationships to Disclose